This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07300/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07300/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07300/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07300/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07300/identifier/pdb/

Statements

Subject Item
n2:DB07300
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07300 n8:DB07300
dcterms:title
2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
adms:identifier
n10:99443771 n11:9BD n12:44176356 n13:24634980 n14:DB07300
n3:IUPAC-Name
n4:271B5DD5-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5DDB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5DDA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5DD7-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5DD8-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5DD9-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5DD3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5DD1-363D-11E5-9242-09173F13E4C5 n4:271B5DD4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5DD2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5DE1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5DE2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5DDC-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5DDD-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5DDF-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5DDE-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5DE0-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5DE6-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5DE8-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5DE9-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5DE5-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5DE4-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5DE7-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5DD6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5DE3-363D-11E5-9242-09173F13E4C5